|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
847057887 |
| 003 |
DE-627 |
| 005 |
20240422233114.0 |
| 007 |
tu |
| 008 |
160203s2016 gw ||||| 00| ||ger c |
| 015 |
|
|
|a 16,A17
|2 dnb
|
| 016 |
7 |
|
|a 1081677023
|2 DE-101
|
| 020 |
|
|
|a 3871934291
|c : Broschur : EUR 74.90 (AT), EUR 72.76 (DE)
|9 3-87193-429-1
|
| 020 |
|
|
|a 9783871934292
|c : Broschur : EUR 74.90 (AT), EUR 72.76 (DE)
|9 978-3-87193-429-2
|
| 024 |
3 |
|
|a 9783871934292
|
| 028 |
5 |
2 |
|a 001103
|
| 035 |
|
|
|a (DE-627)847057887
|
| 035 |
|
|
|a (DE-576)455631840
|
| 035 |
|
|
|a (DE-599)DNB1081677023
|
| 035 |
|
|
|a (OCoLC)936776268
|
| 035 |
|
|
|a (OCoLC)936776268
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a ger
|
| 044 |
|
|
|c XA-DE-BW
|
| 082 |
0 |
|
|a 615.190021843
|2 22/ger
|
| 082 |
0 |
4 |
|a 610
|q DNB
|
| 082 |
0 |
4 |
|a 004
|
| 084 |
|
|
|a 58.28
|2 bkl
|
| 245 |
1 |
0 |
|a GMP-/FDA-Anforderungen an die Qualitätssicherung
|b Qualitätssicherungssystem, GMP-Compliance, Lieferantenqualifizierung, GMP-relevante Verträge
|c Herausgeber: Concept Heidelberg
|
| 250 |
|
|
|a 2. , überarbeitete Auflage
|
| 264 |
|
1 |
|a Aulendorf
|b ECV, Editio Cantor Verlag
|c [2016]
|
| 264 |
|
4 |
|c © 2016
|
| 300 |
|
|
|a 215 Seiten
|b Illustrationen
|c 25 cm
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
0 |
|
|a Pharma Technologie Journal
|
| 583 |
1 |
|
|a Archivierung/Langzeitarchivierung gewährleistet
|f PEBW
|x XA-DE-BW
|2 pdager
|5 DE-24
|
| 655 |
|
7 |
|a Aufsatzsammlung
|0 (DE-588)4143413-4
|0 (DE-627)105605727
|0 (DE-576)209726091
|2 gnd-content
|
| 689 |
0 |
0 |
|D g
|0 (DE-588)4011882-4
|0 (DE-627)104704861
|0 (DE-576)208896155
|a Deutschland
|2 gnd
|
| 689 |
0 |
1 |
|D s
|0 (DE-588)4113765-6
|0 (DE-627)104161949
|0 (DE-576)209479167
|a GMP-Regeln
|2 gnd
|
| 689 |
0 |
|
|5 DE-101
|
| 689 |
1 |
0 |
|D b
|0 (DE-588)10985-X
|0 (DE-627)100325572
|0 (DE-576)190211059
|a USA
|b Food and Drug Administration
|2 gnd
|
| 689 |
1 |
1 |
|D s
|0 (DE-588)4113765-6
|0 (DE-627)104161949
|0 (DE-576)209479167
|a GMP-Regeln
|2 gnd
|
| 689 |
1 |
|
|5 DE-101
|
| 689 |
2 |
0 |
|D s
|0 (DE-588)4219057-5
|0 (DE-627)104375736
|0 (DE-576)210253223
|a Qualitätsmanagement
|2 gnd
|
| 689 |
2 |
|
|5 (DE-627)
|
| 710 |
2 |
|
|a Concept Heidelberg GmbH
|e Herausgebendes Organ
|0 (DE-588)2066487-4
|0 (DE-627)103594043
|0 (DE-576)192116193
|4 isb
|
| 710 |
2 |
|
|a ECV Editio Cantor Verlag für Medizin und Naturwissenschaften GmbH
|e Verlag
|0 (DE-588)1065370008
|0 (DE-627)815909268
|0 (DE-576)425039668
|4 pbl
|
| 856 |
4 |
2 |
|u http://deposit.d-nb.de/cgi-bin/dokserv?id=5d502b7fa9104e3eb4e1c654a80eba97&prov=M&dok_var=1&dok_ext=htm
|m X: MVB
|q text/html
|v 2016-04-28
|x Verlag
|3 Inhaltstext
|
| 856 |
4 |
2 |
|u http://d-nb.info/1081677023/04
|m B:DE-101
|q application/pdf
|v 2016-04-28
|x Verlag
|3 Inhaltsverzeichnis
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a ISIL_DE-84
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a SSG-OPC-DE-84
|
| 912 |
|
|
|a GBV_ILN_164
|
| 912 |
|
|
|a ISIL_DE-916
|
| 912 |
|
|
|a GBV_ILN_293
|
| 912 |
|
|
|a ISIL_DE-960-3
|
| 912 |
|
|
|a GBV_ILN_2003
|
| 912 |
|
|
|a ISIL_DE-25
|
| 912 |
|
|
|a GBV_ILN_2008
|
| 912 |
|
|
|a ISIL_DE-24
|
| 912 |
|
|
|a GBV_ILN_2108
|
| 912 |
|
|
|a ISIL_DE-991
|
| 912 |
|
|
|a GBV_ILN_2152
|
| 912 |
|
|
|a ISIL_DE-941
|
| 935 |
|
|
|i Blocktest
|
| 936 |
b |
k |
|a 58.28
|j Pharmazeutische Technologie
|0 (DE-627)106417622
|
| 951 |
|
|
|a BO
|
| 953 |
|
|
|2 045F
|a 615.190021843
|
| 980 |
|
|
|2 20
|1 01
|x 0084
|b 4175002812
|c 00
|f LS2
|d PM C 602 (2016,1)
|e --%%--
|j --%%--
|c 09
|f MAG
|d 2968-9127
|e --%%--
|j --%%--
|y k
|z 11-08-22
|
| 980 |
|
|
|2 164
|1 01
|x 0916
|b 1508295638
|c 00
|f WOB
|d WG Z 092/2
|e u
|j --%%--
|k Weitere Exemplare unter den anderen Auflagen
|y zw
|z 22-11-16
|
| 980 |
|
|
|2 293
|1 01
|x 3293
|b 3557421899
|c 00
|f KSF/FHH
|d MED 6000 /35(2):1
|e s
|j --%%--
|y zf
|z 17-12-19
|
| 980 |
|
|
|2 293
|1 02
|x 3293
|b 3566014419
|c 00
|f KSF/FHH
|d MED 6000 /35(2):2
|e u
|j --%%--
|y zf
|z 17-12-19
|
| 980 |
|
|
|2 2003
|1 01
|x DE-25
|b 321795548X
|c 00
|f --%%--
|d NA 2017/48
|e --%%--
|j --%%--
|y l01
|z 03-02-17
|
| 980 |
|
|
|2 2008
|1 01
|x DE-24
|b 3217955552
|c 00
|f --%%--
|d 68/18200
|e --%%--
|j --%%--
|y l01
|z 19-12-18
|
| 980 |
|
|
|2 2108
|1 01
|x DE-991
|b 3217955579
|c 00
|f --%%--
|d BwQu 640(2)
|e --%%--
|j l
|y l01
|z 18-02-16
|
| 980 |
|
|
|2 2152
|1 01
|x DE-941
|b 3687421821
|c 00
|f --%%--
|d VX 5502 1
|e --%%--
|j l
|y l01
|z 16-06-20
|
| 983 |
|
|
|2 293
|1 00
|x DE-960-3
|8 00
|0 (DE-627)1679061747
|a MED 6000
|b Pharmakologie, Arzneimittelkunde: Allgemeines
|
| 984 |
|
|
|2 20
|1 01
|x 0084
|a 84$103756604
|
| 984 |
|
|
|2 293
|1 01
|x 3293
|a 960$02598035
|
| 984 |
|
|
|2 293
|1 02
|x 3293
|a 960$02598027
|
| 985 |
|
|
|2 293
|1 01
|x 3293
|a fi 2019/0359
|
| 985 |
|
|
|2 293
|1 02
|x 3293
|a fi 2019/0365
|
| 998 |
|
|
|2 2003
|1 01
|x DE-25
|0 1707
|f 18
|
